BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 813921)

  • 1. A case of deficiency of the seventh component of complement in man. Biological properties of a C7-deficient serum and description of a C7-inactivating principle.
    Wellek B; Opferkuch W
    Clin Exp Immunol; 1975 Feb; 19(2):223-35. PubMed ID: 813921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hereditary deficiency of the seventh component of complement.
    Boyer JT; Gall EP; Norman ME; Nilsson UR; Zimmerman TS
    J Clin Invest; 1975 Oct; 56(4):905-13. PubMed ID: 1099121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inherited deficiency of the seventh component of complement associated with nephritis. Propensity to formation of C56 and related C7-consuming activity.
    Nemerow GR; Gewurz H; Osofsky SG; Lint TF
    J Clin Invest; 1978 Jun; 61(6):1602-10. PubMed ID: 350902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hereditary C6 deficiency in man.
    Frank MM; Leddy JP; Gaither T; Heusinkveld RS; Breckenridge RT; Klemperer MR
    Birth Defects Orig Artic Ser; 1975; 11(1):318-21. PubMed ID: 807274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hereditary C7 deficiency. Diagnosis and HLA studies in a French-Canadian family.
    Delâge JM; Bergeron P; Simard J; Lehner-Netsch G; Prochazka E
    J Clin Invest; 1977 Nov; 60(5):1061-9. PubMed ID: 409732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paradoxical reconstitution of complement activity following plasma transfusion of an individual with deficiency of the seventh component of complement.
    Platonov AE; Würzner R; Beloborodov B; Jones AM; Troshansky DV; Vershinina IV; Lachmann PJ; Orren A
    Immunology; 1994 Jan; 81(1):142-8. PubMed ID: 8132211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hereditary deficiency of the fifth component of complement in man. II. Biological properties of C5-deficient human serum.
    Rosenfeld SI; Baum J; Steigbigel RT; Leddy JP
    J Clin Invest; 1976 Jun; 57(6):1635-43. PubMed ID: 777027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human deficiency of the eighth component of complement. The requirement of C8 for serum Neisseria gonorrhoeae bactericidal activity.
    Petersen BH; Graham JA; Brooks GF
    J Clin Invest; 1976 Feb; 57(2):283-90. PubMed ID: 815273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyanate as an inactivator of complement proteins.
    Schultz DR; Arnold PI
    J Immunol; 1975 Dec; 115(6):1558-65. PubMed ID: 1184967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hereditary C5 deficiency in man. III. Studies of hemostasis and platelet responses to zymosan.
    Breckenridge RT; Rosenfeld SI; Graff KS; Leddy JP
    J Immunol; 1977 Jan; 118(1):12-6. PubMed ID: 830743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification of the sixth and seventh component of human complement without loss of hemolytic activity.
    Podack ER; Kolb WP; Müller-Eberhard HJ
    J Immunol; 1976 Feb; 116(2):263-9. PubMed ID: 1249415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined genetic deficiency of C6 and C7 in man.
    Lachmann PJ; Hobart MJ; Woo P
    Clin Exp Immunol; 1978 Aug; 33(2):193-203. PubMed ID: 102474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial deficiency of the seventh component of complement associated with recurrent bacteremic infections due to Neisseria.
    Lee TJ; Utsinger PD; Snyderman R; Yount WJ; Sparling PF
    J Infect Dis; 1978 Sep; 138(3):359-68. PubMed ID: 100562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the complement attack mechanism in the fluid phase and its control by C567-INH: lysis of normal erythrocytes initiated by zymosan, endotoxin, and immune complexes.
    Lint TF; Behrends CL; Baker PJ; Gewurz H
    J Immunol; 1976 Nov; 117(5 Pt 1):1440-6. PubMed ID: 1002985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functionally active complement proteins C6 and C7 detected in C6- and C7-deficient individuals.
    Würzner R; Orren A; Potter P; Morgan BP; Ponard D; Späth P; Brai M; Schulze M; Happe L; Götze O
    Clin Exp Immunol; 1991 Mar; 83(3):430-7. PubMed ID: 2004484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective deficiency of the fourth component of complement in a patient with systemic lupus erythematosus (SLE): immunochemical and biological studies.
    Minta JO; Urowitz MB; Gladman DD; Irizawa T; Biggar WD
    Clin Exp Immunol; 1981 Jul; 45(1):72-80. PubMed ID: 6796316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial late complement component (C6, C7) deficiency with chronic meningococcemia.
    Clough JD; Clough ML; Weinstein A; Calabrese LH; Mansfield LR; Gulick P; Gavan T; Braun WE
    Arch Intern Med; 1980 Jul; 140(7):929-33. PubMed ID: 7387302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The complement profile in relation to the "reactor" state: a study in the immediate post-partum period.
    Mak LW
    Clin Exp Immunol; 1978 Mar; 31(3):419-25. PubMed ID: 657587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inherited deficiency of the seventh component of complement associated with meningococcal meningitis: lack of serum bactericidal activity against Neisseria meningitidis in a girl with C7 deficiency and HLA studies of a C7-deficient Japanese family.
    Miyake T; Ohta K; Kawamori J; Hirao T; Akagaki Y; Inai S
    Microbiol Immunol; 1986; 30(4):363-72. PubMed ID: 3088400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement-mediated serum cytotoxicity for Leishmania major amastigotes: killing by serum deficient in early components of the membrane attack complex.
    Hoover DL; Berger M; Hammer CH; Meltzer MS
    J Immunol; 1985 Jul; 135(1):570-4. PubMed ID: 3998474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.